Related Experiment Videos
Mos is degraded by the 26S proteasome in a ubiquitin-dependent fashion
1Central Research Laboratories, Santen Pharmaceutical Co., Ltd., Osaka, Japan.
Abstract:
Mos, the c-mos proto-oncogene product, is a key regulator of cell cycle progression. Recently, rapid turnover of Mos in an early stage of meiotic maturation of Xenopus oocytes was found to be mediated by the ubiquitin pathway, but the protease responsible for its breakdown was not identified. In the present study, we found that 35S-labeled Mos synthesized in an in vitro transcription/translation system was degraded ATP- and time-dependently by the 26S proteasome, but not by the 20S proteasome, in the presence of a ubiquitin-ligation system. The 26S proteasome did not degrade a mutant Mos in which Ser3 was replaced by Asp3 that is metabolically stable in oocytes, indicating a similarity in the proteolytic events in vivo to those observed in vitro in the present work. This is the first demonstration that the proteasome catalyzes the ATP-dependent degradation of a naturally occurring, short-lived oncoprotein by the ubiquitin pathway. This finding suggests that the proteasome may regulate the intracellular stability of various oncoproteins.
Insights
The proteasome degrades the c-mos proto-oncogene product (Mos) through the ubiquitin pathway. This ATP-dependent process is crucial for regulating cell cycle progression and oncoprotein stability.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Mos, the c-mos proto-oncogene product, is vital for cell cycle regulation.
- Previous studies indicated Mos turnover during Xenopus oocyte maturation involves the ubiquitin pathway, but the specific protease remained unknown.
Purpose of the Study:
- To identify the protease responsible for Mos degradation.
- To elucidate the mechanism of Mos breakdown in vitro and compare it to in vivo observations.
Main Methods:
- In vitro transcription/translation of 35S-labeled Mos.
- Incubation with a ubiquitin-ligation system and the 26S proteasome.
- Degradation assays using wild-type and mutant Mos (Ser3 to Asp3).
Main Results:
- The 26S proteasome, not the 20S proteasome, degraded Mos in an ATP- and time-dependent manner.
- A mutant Mos (Ser3Asp3), stable in oocytes, was resistant to 26S proteasome degradation.
- This demonstrates the proteasome's role in the ATP-dependent, ubiquitin-mediated degradation of Mos.
Conclusions:
- The proteasome catalyzes the ATP-dependent degradation of the oncoprotein Mos via the ubiquitin pathway.
- This finding highlights the proteasome's potential role in regulating the stability of various oncoproteins.